Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 179
Filtrar
1.
Clin Oncol (R Coll Radiol) ; 35(2): 80-81, 2023 02.
Artigo em Inglês | MEDLINE | ID: mdl-36639182
2.
Clin Colon Rectal Surg ; 35(4): 265-268, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35966984

RESUMO

This article summarizes the events that shaped our current understanding of the mesentery and the abdomen. The story of how this evolved is intriguing at several levels. It speaks to considerable personal commitment on the part of the pioneers involved. It explains how scientific and clinical fields went different directions with respect to anatomy and clinical practice. It demonstrates that it is no longer acceptable to adhere unquestioningly to models of abdominal anatomy and surgery. The article concludes with a brief description of the Mesenteric Model of abdominal anatomy, and of how this now presents an opportunity to unify scientific and clinical approaches to the latter.

5.
Colorectal Dis ; 21(3): 270-276, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30489676

RESUMO

AIM: Surgery for rectal cancer is challenging for both technical and anatomical reasons. The European Academy of Robotic Colorectal Surgery (EARCS) provides a competency-based training programme through a standardized approach. However, there is no consensus on technical standards for robotic surgery when used during surgery for rectal cancer. The aim of this consensus study was to establish operative standards for anterior resection incorporating total mesorectal excision (TME) using robotic techniques, based on recommendations of expert European colorectal surgeons. METHOD: A Delphi questionnaire with a 72-item statement was sent through an electronic survey tool to 24 EARCS faculty members from 10 different countries who were selected based on expertise in robotic colorectal surgery. The task was divided into theatre setup, colonic mobilization and rectal dissection, and each task area was further divided into several subtasks. The levels of agreement (A* > 95% agreement, A > 90%, B > 80% and C > 70%) were considered adequate while agreement of < 70% was considered inadequate. Once consensus was reached, a draft document was compiled and sent out for final approval. RESULTS: The average length of experience of robotic colorectal surgery for participants in this study was 6 years. Initial agreement was 87%; in nine items, it was < 70%. After suggested modifications, the average level of agreement for all items reached 94% in the second round (range 0.75-1). CONCLUSION: This is the first European consensus on the standardization of robotic TME. It provides a baseline for technical standards and structured training in robotic rectal surgery.


Assuntos
Protectomia/normas , Neoplasias Retais/cirurgia , Procedimentos Cirúrgicos Robóticos/normas , Adulto , Idoso , Consenso , Técnica Delphi , Europa (Continente) , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Protectomia/métodos , Padrões de Referência , Procedimentos Cirúrgicos Robóticos/métodos
6.
Colorectal Dis ; 20 Suppl 1: 8-11, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29878671

RESUMO

In this personal account Professor Heald discusses the international implementation of total mesorectal excision for rectal cancer and the development of a generation of "specimen-orientated" surgeons. He describes the importance of the surgeon, radiologist and pathologist working together to improve techniques in all three disciplines and the research challenges for the future.


Assuntos
Comunicação Interdisciplinar , Imageamento por Ressonância Magnética/métodos , Protectomia/métodos , Neoplasias Retais/diagnóstico por imagem , Neoplasias Retais/cirurgia , Biópsia por Agulha , Congressos como Assunto , Humanos , Imuno-Histoquímica , Mesocolo/cirurgia , Patologistas , Equipe de Assistência ao Paciente/organização & administração , Radiologistas , Neoplasias Retais/patologia , Cirurgiões , Resultado do Tratamento
9.
Colorectal Dis ; 19(1): O1-O12, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27671222

RESUMO

The reduction of the incidence, detection and treatment of anastomotic leakage (AL) continues to challenge the colorectal surgical community. AL is not consistently defined and reported in clinical studies, its occurrence is variably reported and its impact on longterm morbidity and health-care resources has received relatively little attention. Controversy continues regarding the best strategies to reduce the risk. Diagnostic tests lack sensitivity and specificity, resulting in delayed diagnosis and increased morbidity. Intra-operative fluorescence angiography has recently been introduced as a means of real-time assessment of anastomotic perfusion and preliminary evidence suggests that it may reduce the rate of AL. In addition, concepts are emerging about the role of the rectal mucosal microbiome in AL and the possible role of new prophylactic therapies. In January 2016 a meeting of expert colorectal surgeons and pathologists was held in London, UK, to identify the ongoing controversies surrounding AL in colorectal surgery. The outcome of the meeting is presented in the form of research challenges that need to be addressed.


Assuntos
Fístula Anastomótica , Cirurgia Colorretal/tendências , Enterostomia/efeitos adversos , Humanos , Reino Unido
10.
Colorectal Dis ; 19(6): 537-543, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27673438

RESUMO

AIM: MRI-detected extramural venous invasion (mrEMVI) is a poor prognostic factor in rectal cancer. Preoperative chemoradiotherapy (CRT) can cause regression in the severity of EMVI and subsequently improve survival whereas mrEMVI persisting after CRT confers an increased risk of recurrence. The effect of adjuvant chemotherapy (AC) following CRT on survival in rectal cancer remains unclear. The aim of this study was to determine whether there is a survival advantage for AC given to patients with mrEMVI persisting after CRT. METHOD: A prospective analysis was conducted of consecutive patients with locally advanced rectal cancer between 2006 and 2013. All patients underwent CRT followed by surgery. AC was given to selected patients based on the presence of specific 'high-risk' features. Comparison was made between patients offered AC with observation alone. The primary outcome was 3-year disease-free survival (DFS). RESULTS: Of 631 patients, 227 (36.0%) demonstrated persistent mrEMVI following CRT. Patients were grouped on the basis of AC or observation and were matched for age, performance status and final histopathological staging. Three-year DFS in the AC group was 74.6% compared with 53.7% in the observation only group. AC had a survival benefit on multivariate analysis (hazard ratio 0.458; 95% CI: 0.271-0.775, P = 0.004). CONCLUSION: Patients with persistent mrEMVI following CRT who receive AC may have a decreased risk of recurrence and an improved 3-year DFS compared with patients not receiving AC, irrespective of age and performance status.


Assuntos
Antineoplásicos/uso terapêutico , Quimiorradioterapia/efeitos adversos , Imageamento por Ressonância Magnética/métodos , Recidiva Local de Neoplasia/tratamento farmacológico , Neoplasias Retais/terapia , Idoso , Quimioterapia Adjuvante/métodos , Bases de Dados Factuais , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica/diagnóstico por imagem , Recidiva Local de Neoplasia/diagnóstico por imagem , Recidiva Local de Neoplasia/patologia , Modelos de Riscos Proporcionais , Estudos Prospectivos , Neoplasias Retais/diagnóstico por imagem , Neoplasias Retais/patologia , Reto/irrigação sanguínea , Reto/patologia , Estudos Retrospectivos , Resultado do Tratamento
14.
Ann R Coll Surg Engl ; 96(7): 543-6, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25245736

RESUMO

INTRODUCTION: There remains a lack of high quality randomised trial evidence for the use of adjuvant chemotherapy in stage II rectal cancer, particularly in the presence of high risk features such as extramural venous invasion (EMVI). The aim of this study was to explore this issue through a survey of colorectal surgeons and gastrointestinal oncologists. METHODS: An electronic survey was sent to a group of colorectal surgeons who were members of the Association of Coloproctology of Great Britain and Ireland. The survey was also sent to a group of gastrointestinal oncologists through the Pelican Cancer Foundation. Reminder emails were sent at 4 and 12 weeks. RESULTS: A total of 142 surgeons (54% response rate) and 99 oncologists (68% response rate) responded to the survey. The majority in both groups of clinicians thought EMVI was an important consideration in adjuvant treatment decision making and commented routinely on this in their multidisciplinary team meeting. Although both would consider treating patients on the basis of EMVI detected by magnetic resonance imaging, oncologists were more selective. Both surgeons and oncologists were prepared to offer patients with EMVI adjuvant chemotherapy but there was lack of consensus on the benefit. CONCLUSIONS: This survey reinforces the evolution in thinking with regard to adjuvant therapy in stage II disease. Factors such as EMVI should be given due consideration and the prognostic information we offer patients must be more accurate. Historical data may not accurately reflect today's practice and it may be time to consider an appropriately designed trial to address this contentious issue.


Assuntos
Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/patologia , Imageamento por Ressonância Magnética/métodos , Inquéritos e Questionários , Neoplasias Vasculares/tratamento farmacológico , Neoplasias Vasculares/secundário , Quimioterapia Adjuvante , Colectomia/métodos , Neoplasias Colorretais/cirurgia , Tomada de Decisões , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Invasividade Neoplásica/patologia , Padrões de Prática Médica/tendências , Prognóstico , Medição de Risco , Resultado do Tratamento , Reino Unido , Neoplasias Vasculares/patologia , Neoplasias Vasculares/cirurgia
15.
Int J Colorectal Dis ; 29(4): 419-28, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24477788

RESUMO

BACKGROUND: It has been evident for a while that the result after resection for colon cancer may not have been optimal. Several years ago, this was showed by some leading surgeons in the USA but a concept of improving results was not consistently pursued. Later, surgeons in Europe and Japan have increasingly adopted the more radical principle of complete mesocolic excision (CME) as the optimal approach for colon cancer. The concept of CME is a similar philosophy to that of total mesorectal excision for rectal cancer and precise terminology and optimal surgery are key factors. METHOD: There are three essential components to CME. The main component involves a dissection between the mesenteric plane and the parietal fascia and removal of the mesentery within a complete envelope of mesenteric fascia and visceral peritoneum that contains all lymph nodes draining the tumour area (Hohenberger et al., Colorectal Disease 11:354-365, 2009; West et al., J Clin Oncol 28:272-278, 2009). The second component is a central vascular tie to completely remove all lymph nodes in the central (vertical) direction. The third component is resection of an adequate length of bowel to remove involved pericolic lymph nodes in the longitudinal direction. RESULT: The oncological rationale for CME and various technical aspects of the surgical management will be explored. CONCLUSION: The consensus conference agreed that there are sound oncological hypotheses for a more radical approach than has been common up to now. However, this may not necessarily apply in early stages of the tumour stage. Laparoscopic resection appears to be equally well suited for resection as open surgery.


Assuntos
Colectomia/métodos , Neoplasias do Colo/cirurgia , Mesocolo/cirurgia , Neoplasias do Colo/irrigação sanguínea , Neoplasias do Colo/patologia , Dissecação/métodos , Fasciotomia , Humanos , Laparoscopia/métodos , Ligadura , Excisão de Linfonodo , Metástase Linfática , Invasividade Neoplásica , Micrometástase de Neoplasia , Estadiamento de Neoplasias , Procedimentos Cirúrgicos Vasculares
20.
Colorectal Dis ; 14(10): e655-60, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22788385

RESUMO

AIM: Extralevator abdominoperineal excision in the prone position has been reported as a method to improve the poor outcome sometimes observed after abdominoperineal excision (APE) for low rectal cancer. In this paper a pictorial guide is presented describing the key anatomical steps and landmarks of the operation. METHOD: Intraoperative footage of five APE operations filmed in high definition was reviewed and key stages of the operation were identified. Still frames were captured from these sequences to illustrate this guide. An edited video sequence was produced from one of these operations to accompany this paper. CONCLUSION: The prone APE allows improved visualization of the perineal portion of the operation by the surgeon, assistants and observers. It permits clear demonstration for teaching. Prospective evaluation is still required to identify patients who would benefit from extralevator APE.


Assuntos
Abdome/cirurgia , Períneo/cirurgia , Neoplasias Retais/cirurgia , Reto/cirurgia , Feminino , Humanos , Masculino , Posicionamento do Paciente , Decúbito Ventral , Técnicas de Fechamento de Ferimentos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...